financetom
Business
financetom
/
Business
/
What's Going On With Bitcoin Mining Stock Riot Platforms Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Bitcoin Mining Stock Riot Platforms Tuesday?
Dec 10, 2024 8:59 AM

Riot Platforms Inc ( RIOT ) shares are seeing increased attention Tuesday after the company announced an upsized offering of convertible senior notes.

What Happened: Riot announced the pricing of a $525 million offering of its 0.75% convertible senior notes due 2030. The notes will be sold in a private offering to qualified institutional buyers.

The offering was upsized from the previously announced offering of $500 million. The company also plans to grant the initial purchasers a three-day period to buy up to an additional $75 million of the notes.

Riot anticipates net proceeds of approximately $511.5 million, and the offering is expected to close on Wednesday. The company intends to use the proceeds to purchase additional Bitcoin (CRYPTO: BTC).

Investors appear to be digesting details of the strategy. The market has bid up other crypto-linked stocks like MicroStrategy and MARA Holdings in recent months after announcing plans to raise capital to accumulate Bitcoin.

Check This Out: EXCLUSIVE: Bitcoin To End The Year Above $100,000? ‘Bulls Failed Again’ At This Key Level, Experts Say

Bitcoin is trading lower on Tuesday and was down 1.69% over a 24-hour period at the time of publication, which appears to be adding some selling pressure to bitcoin mining stocks and other crypto-related names.

Riot said last week that it mined 495 Bitcoin in November, down about 2% from October. The company held a total of 11,425 Bitcoin as of the end of November.

RIOT Price Action: Riot Platforms ( RIOT ) shares were down 2.63% at $10.92 at the time of publication, according to Benzinga Pro.

Read Next:

Bitcoin Crashing? ‘Mundane’ Reasons, Says Bernstein: ‘Buy The Dip’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CACI International Awarded $314 Million Task Order
CACI International Awarded $314 Million Task Order
Sep 26, 2024
05:27 PM EDT, 09/24/2024 (MT Newswires) -- CACI International ( CACI ) said Tuesday it has been awarded a five-year task order worth up to $314 million to provide engineering services and technology to the US Navy's Naval Undersea Warfare Center. CACI ( CACI ) said it will develop, deliver, and train sailors in the areas of integration support, logistics,...
Theralase Technologies Completes C$544,000 Non-Brokered Private Placement of Share Units
Theralase Technologies Completes C$544,000 Non-Brokered Private Placement of Share Units
Sep 26, 2024
05:26 PM EDT, 09/24/2024 (MT Newswires) -- Theralase Technologies ( TLTFF ) said Tuesday it closed a non-brokered private placement of share units that raised C$544,000. The company said it placed 2.72-million units in the financing, with each priced at $0.20 and made up of a share and a five-year warrant to buy a second share for $0.30. Proceeds will...
FAA will notify DOJ if Boeing engages in any criminal activities
FAA will notify DOJ if Boeing engages in any criminal activities
Sep 26, 2024
Sept 24 (Reuters) - The head of the Federal Aviation Administration will tell a U.S. Senate panel on Wednesday that the agency will remain engaged with the Justice Department on oversight of Boeing ( BA ). FAA Administrator Mike Whitaker will tell the Senate Permanent Subcommittee on Investigations that the agency will expeditiously provide notice, in real time, of any...
Fulcrum Therapeutics to Cut Jobs, Reprioritize R&D Activities
Fulcrum Therapeutics to Cut Jobs, Reprioritize R&D Activities
Sep 26, 2024
05:27 PM EDT, 09/24/2024 (MT Newswires) -- Fulcrum Therapeutics ( FULC ) said Tuesday its board has approved a restructuring plan that will trim its workforce to 51 full-time employees from 80. The company said its goal is to reprioritize research and development activities to focus on advancing pociredir for the treatment of sickle cell disease, novel therapeutic agents for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved